This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Traumatic cerebral oedema
ST19_TRAUMAT_CEREBRAL_OEDEMA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
120 |
4. Check minimum number of eventsNone |
120 |
5. Include endpointsNone |
120 |
6. Filter based on genotype QC (FinnGen only) |
120 |
Control definitions (FinnGen only)
- Control exclude
- NEURODIS
Extra metadata
- Level in the ICD hierarchy
- 4
- Special
- ST19_TRAUMCOEDMA
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- S06
- Name in latin
- Oedema cerebri/encephali traumaticum
Similar endpoints
↥List of similar endpoints to
Traumatic cerebral oedema
based on the number of shared cases.
Similar with more cases:
- Intracranial injury
- Intracranial trauma
- Injuries to the head
- Neurological diseases, wide definition
- Injury, poisoning and certain other consequences of external causes
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 120 | 46 | 74 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.03 |
| Median age at first event (years) | 49.31 | 46.28 | 51.20 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 108
- Matched controls
- 1080
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S06.1
ICD-10 Finland
Traumatic cerebral oedema
+∞
155.8
108
*
S06.0
ICD-10 Finland
Concussion
52.2
32.4
38
11
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
+∞
29.5
27
*
AA1AD
NOMESCO Finland
CT of head and brain
15.2
26.3
47
52
T90.5
ICD-10 Finland
Sequelae of intracranial injury
160.7
24.8
25
*
S06.2
ICD-10 Finland
Diffuse brain injury
+∞
22.7
21
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
16.0
15
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
6.0
14.7
49
132
S06.3
ICD-10 Finland
Focal brain injury
+∞
13.8
13
*
W19
ICD-10 Finland
Unspecified fall
9.8
12.2
25
32
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
10.6
10
*
R51.80
ICD-10 Finland
Headache
7.2
10.2
25
43
S42.0
ICD-10 Finland
Fracture of clavicle
24.3
9.6
13
6
N03AX14
ATC
levetiracetam; systemic
+∞
9.5
9
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.7
9.4
28
62
N03AF02
ATC
oxcarbazepine; oral
40.4
9.2
11
*
G47.3
ICD-10 Finland
Sleep apnoea
14.4
8.7
14
11
G40.9
ICD-10 Finland
Epilepsy, unspecified
+∞
8.4
8
*
AAF00
NOMESCO Finland
Ventriculostomy
+∞
8.4
8
*
JN5BD
NOMESCO Finland
Head and body CT examination for trauma
36.4
8.2
10
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
48.6
7.8
9
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
11.3
7.8
14
14
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
5.6
7.6
22
47
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
85.7
7.5
8
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
7.5
7.5
17
26
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
+∞
7.4
7
*
AAA27
NOMESCO Finland
Insertion of intracerebral pressure monitoring device
+∞
7.4
7
*
S02.11
ICD-10 Finland
Fracture of base of skull, open
+∞
7.4
7
*
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
+∞
7.4
7
*
X59
ICD-10 Finland
Exposure to unspecified factor
4.0
7.3
31
98
G44.2
ICD-10 Finland
Tension-type headache
8.0
7.3
16
23
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
9.9
7.3
14
16
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
9.9
7.3
14
16
XA800
NOMESCO Finland
Neuropsychological investigation
32.4
7.3
9
*
N03AX12
ATC
gabapentin; oral
6.2
7.2
19
36
R56.8
ICD-10 Finland
Other and unspecified convulsions
10.4
7.0
13
14
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
11.1
6.7
12
12
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
74.0
6.5
7
*
S02.10
ICD-10 Finland
Fracture of base of skull, closed
74.0
6.5
7
*
N80
ICPC
Head injury other
74.0
6.5
7
*
N06AB04
ATC
citalopram; systemic
3.8
6.5
29
96
S06.4
ICD-10 Finland
Epidural haemorrhage
+∞
6.3
6
*
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
+∞
6.3
6
*
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
+∞
6.3
6
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
+∞
6.3
6
*
W17
ICD-10 Finland
Other fall from one level to another
11.0
6.2
11
11
N05BA04
ATC
oxazepam; oral
3.6
6.1
29
100
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
30
6.00
8.46
13.9
8.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
32
139
2.78
5.27
5.2
3.0
ng/l
9.0
281.2
1.14
22
112
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
7
5
14.74
4.63
1.7
1.2
mmol/l
4.5
3.4
—
7
5
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
7
6
12.28
4.33
1.6
1.3
mg/l
480.7
320.7
—
7
6
(3003396) Base excess in Arterial blood by calculation
19
72
2.95
3.95
13.1
6.6
mmol/l
1.3
0.3
0.33
13
57
(3044290) Cell count panel - Cerebral spinal fluid
6
5
12.53
3.80
2.0
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
57
366
2.06
3.67
8.4
5.5
mmol/l
1.2
1.2
0.14
44
314
(3023368) Bacteria identified in Blood by Culture
34
190
2.10
3.09
5.3
3.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
48
306
1.95
3.03
6.4
7.2
inr
1.3
1.3
0.17
13
79
(3023419) Bacteria identified in Sputum by Culture
5
7
7.39
2.57
2.8
2.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
18
83
2.37
2.56
1.9
1.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
11
39
3.00
2.55
5.2
5.9
mmol/l
23.1
24.5
0.47
11
39
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
16
4.57
2.51
1.3
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
23
121
2.11
2.41
1.9
1.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
76
591
1.78
2.35
4.4
3.4
pmol/l
14.6
14.7
0.02
68
520
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
18
87
2.26
2.31
2.1
1.6
—
—
—
0
0
(3012544) pH of Venous blood
16
75
2.31
2.20
3.2
3.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
14
4.45
2.18
1.7
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
11
43
2.72
2.16
17.4
3.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
11
4.69
1.96
1.6
3.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
12
52
2.45
1.95
3.7
3.1
ng/l
92.7
221.8
1.51
12
46
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
90
758
1.75
1.88
5.0
3.9
mu/l
2.0
1.9
0.29
82
671
(40768797) Stomach Pathology biopsy report
18
95
2.05
1.87
1.2
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
39
266
1.69
1.84
3.5
2.9
e6/l
21.3
26.1
0.22
32
195
(3022313) Gas panel - Capillary blood
7
25
2.91
1.67
1.1
3.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
63
2.19
1.67
1.8
1.7
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
5
14
3.68
1.63
2.4
2.1
ug/l
105.0
434.5
—
5
14
(3002032) Base excess in Venous blood by calculation
14
71
2.10
1.61
3.4
3.2
mmol/l
0.6
1.2
—
9
50
(42870588) Differential panel, method unspecified - Blood
39
275
1.62
1.60
5.2
4.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
13
68
2.02
1.39
6.1
7.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
34
240
1.58
1.37
3.6
3.0
e6/l
0.1
0.3
0.56
28
174
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
76
1.95
1.36
2.2
1.8
—
—
—
0
0
(3026782) Osmolality of Urine
26
173
1.64
1.32
2.0
2.5
mosm/kgh2o
523.6
572.4
0.45
21
147
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
22
140
1.70
1.32
3.5
2.6
e6/l
10.0
2.2
1.00
14
69
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
25
166
1.64
1.28
1.6
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
68
565
1.47
1.25
4.7
3.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
5
19
2.70
1.23
2.6
1.7
u/ml
0.3
0.3
—
5
12
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
41
310
1.49
1.20
3.2
2.9
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
33
0.00
1.18
0.0
1.6
—
34.1
—
0
33
(3000850) Epithelial cells [#/volume] in Urine
25
170
1.59
1.17
2.5
2.6
e6/l
5.6
3.6
0.29
20
152
(3021589) Normoblasts [#/volume] in Blood
52
415
1.45
1.15
7.4
7.4
e9/l
0.0
0.0
0.50
42
341
(3011288) Drugs identified in Urine by Screen method
8
40
2.07
1.14
1.6
2.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
30
215
1.53
1.12
5.1
3.8
ph
7.4
7.4
—
8
36
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
10
52
2.01
1.09
1.6
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
75
647
1.42
1.05
7.7
6.4
u/l
82.5
77.6
0.41
69
588
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
21
142
1.58
1.01
3.4
2.5
e6/l
4.4
0.7
0.48
13
71
(3018095) Leukocytes [#/volume] in Urine
39
303
1.43
0.98
4.1
3.2
e6/l
40.5
77.7
0.45
33
202
(3000764) Benzodiazepines [Presence] in Urine
11
62
1.85
0.98
1.5
2.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
9
51
1.83
0.97
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
19
271
0.64
0.95
1.8
1.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
49
399
1.39
0.94
7.9
4.9
%
2.7
2.8
0.26
44
372
(3027944) Amphetamines [Presence] in Urine
11
63
1.82
0.93
1.5
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
32
242
1.44
0.92
3.5
2.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
25
182
1.47
0.87
1.3
1.2
u/ml
0.9
0.8
—
9
51
(3042936) Bacteria identified in Isolate by Culture
16
105
1.60
0.87
2.0
1.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
8
46
1.79
0.84
1.4
1.5
g/l
0.9
1.1
—
8
41
(3019832) Treponema pallidum Ab [Presence] in Serum
18
123
1.55
0.83
1.7
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
125
0.53
0.83
1.0
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
47
1.75
0.82
1.6
2.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
30
230
1.41
0.80
3.6
2.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
30
231
1.40
0.78
3.6
2.9
—
—
—
0
0
(3044889) 12 lead EKG panel
68
595
1.33
0.78
3.8
3.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
17
117
1.53
0.77
1.4
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
6
106
0.54
0.77
1.3
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
13
84
1.61
0.75
1.8
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
12
180
0.63
0.75
3.3
2.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
57
1.63
0.73
1.7
2.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
25
322
0.72
0.72
2.7
2.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
5
26
1.96
0.71
1.4
1.3
—
—
—
0
0
(1002224) Polysomnography panel
5
27
1.89
0.69
1.0
1.0
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
7
43
1.67
0.68
7.1
8.5
%
1.0
1.2
—
7
43
(40761536) Microorganisms panel - Urine sediment
11
70
1.63
0.68
2.9
3.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
28
1.82
0.67
1.4
1.0
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
7
44
1.63
0.66
7.1
8.3
%
84.5
95.1
—
7
44
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
7
44
1.63
0.66
6.9
8.3
%
0.6
0.7
—
7
44
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
101
0.57
0.65
7.0
6.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
63
1.64
0.64
1.6
2.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
12
80
1.56
0.62
4.6
2.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
30
1.69
0.62
1.2
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
8
51
1.61
0.62
1.0
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
27
213
1.35
0.61
2.1
2.0
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
20
0.00
0.61
0.0
2.1
—
0.2
—
0
20
(3028300) Cannabinoids [Presence] in Urine
10
64
1.61
0.60
1.6
2.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
2.1
—
1.1
—
0
21
(3029937) Albumin [Presence] in Urine by Test strip
27
214
1.34
0.59
3.2
3.3
estimate
0.0
0.0
0.00
11
76
(3026493) Urate [Moles/volume] in Serum or Plasma
25
196
1.35
0.59
4.4
2.4
umol/l
342.6
6310.1
1.01
20
169
(3052851) Hemolysis interference index of Serum or Plasma
0
23
0.00
0.59
0.0
3.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
10
66
1.56
0.54
6.0
5.9
mmol/l
1.6
1.5
—
10
61
(3015377) Calcium [Moles/volume] in Serum or Plasma
30
247
1.29
0.51
1.7
3.2
mmol/l
2.3
2.4
0.32
25
209
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
45
391
1.24
0.49
5.2
3.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
46
1.55
0.49
1.7
1.2
—
—
—
0
0
(3000492) Spirometry study
5
82
0.59
0.47
1.0
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
21
167
1.31
0.46
1.5
1.3
g/l
2.9
2.5
0.29
15
113
(3048689) Calprotectin [Mass/mass] in Stool
13
96
1.40
0.43
1.9
2.5
ug/g
359.4
187.2
—
8
69
(3022621) pH of Urine by Test strip
8
56
1.46
0.43
1.1
2.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
5
31
1.64
0.43
2.2
1.9
%
1.3
1.1
—
5
31
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
96
912
1.26
0.42
19.8
10.6
mg/l
24.3
24.7
0.04
78
677
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
16
0.00
0.41
0.0
1.3
—
0.0
—
0
16
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
0
16
0.00
0.41
0.0
1.3
—
37.7
—
0
16
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
16
0.00
0.41
0.0
1.3
—
0.0
—
0
16
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
19
0.00
0.39
0.0
1.2
—
8.8
—
0
19
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
114
0.68
0.39
1.0
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
36
1.41
0.38
1.2
2.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
90
855
1.21
0.35
4.0
3.8
mmol/l
5.9
5.8
0.18
81
768
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
6
44
1.38
0.35
1.7
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
83
874
0.84
0.34
21.8
11.1
%
40.3
40.7
0.18
59
680
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
98
0.70
0.32
1.7
2.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
13
102
1.31
0.31
1.5
1.3
—
—
—
0
0
(3015736) pH of Urine
36
321
1.17
0.29
4.3
2.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
84
800
1.17
0.28
5.0
4.8
mmol/mol
39.2
38.6
0.21
78
738
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
64
601
1.14
0.25
3.9
3.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
78
816
0.87
0.24
26.7
13.5
g/l
332.9
333.7
0.30
78
809
(3021601) Nitrite [Presence] in Urine by Test strip
44
404
1.14
0.24
6.1
4.2
estimate
0.0
0.0
0.00
11
78
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
31
278
1.16
0.23
5.4
3.2
ng/l
19.1
53.4
1.53
20
174
(3001604) Monocytes [#/volume] in Blood
45
415
1.13
0.23
7.0
4.9
e9/l
0.6
0.6
0.05
40
358
(40761511) CBC panel - Blood by Automated count
99
960
1.18
0.23
16.7
9.9
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
5
40
1.26
0.22
1.2
2.6
u/ml
9.4
6165.4
—
5
35
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
12
0.00
0.21
0.0
3.8
—
5.1
—
0
12
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
13
0.00
0.21
0.0
3.8
—
58.1
—
0
13
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
17
146
1.19
0.20
3.2
2.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
3.6
—
64.9
—
0
14
(40768793) Breast Pathology biopsy report
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
51
1.19
0.19
1.0
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
44
410
1.12
0.18
4.6
3.0
estimate
0.0
0.0
0.00
11
80
(3021879) Hepatitis B virus core Ab [Presence] in Serum
6
77
0.77
0.16
1.3
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
35
325
1.11
0.15
5.1
3.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
52
494
1.09
0.14
10.4
8.4
e9/l
4.2
4.1
0.13
47
430
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
83
854
0.91
0.14
3.6
3.4
mmol/l
1.3
1.3
0.34
75
776
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
8
97
0.81
0.14
2.0
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
86
883
0.91
0.14
4.2
3.7
mmol/l
4.6
4.6
0.20
79
810
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
88
902
0.91
0.13
4.4
4.1
mmol/l
2.7
2.7
0.01
82
826
(3009261) Glucose [Presence] in Urine by Test strip
44
417
1.09
0.13
3.6
3.0
estimate
0.0
0.0
0.00
11
73
(3049717) Cytology report of Urine Cyto stain
5
43
1.17
0.10
1.2
2.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
6
57
1.06
0.08
2.2
2.5
ug/l
9.7
8.6
—
6
50
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
66
1.06
0.08
1.6
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
21
196
1.09
0.07
5.7
2.9
kg/l
1.0
1.0
—
7
25
(3000494) Fungus identified in Specimen by Culture
8
90
0.88
0.07
1.3
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
22
207
1.08
0.06
6.7
6.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
21
198
1.07
0.06
3.0
2.8
mg/l
32.5
73.5
0.84
16
125
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
86
873
0.95
0.05
4.0
3.7
mmol/l
1.4
1.4
0.04
78
797
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
28
292
0.95
0.05
2.4
1.8
pmol/l
82.1
89.7
0.46
17
152
(40760892) CBC W Ordered Manual Differential panel - Blood
20
189
1.07
0.05
10.3
3.8
—
—
—
0
0
(3013512) EKG study
23
220
1.06
0.04
3.7
3.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
14
132
1.07
0.02
2.1
3.0
mmol/l
2.4
2.4
—
9
114
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
21
202
1.05
0.02
2.4
2.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
26
267
0.97
0.01
3.0
2.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
32
327
0.97
0.01
3.1
2.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
12
114
1.06
0.01
1.4
1.2
iu/ml
34.8
34.9
—
5
30
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
17
169
1.01
0.00
1.5
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
28
283
0.99
0.00
5.8
4.1
%
17.4
21.4
0.62
15
129
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
128
1.02
0.00
3.5
2.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
87
866
1.02
0.00
15.5
10.3
ml/min/173m2
89.2
85.4
0.74
78
698
(3020682) Albumin/Creatinine [Ratio] in Urine
21
211
0.99
0.00
3.9
3.6
mg/mmol
5.2
13.9
0.83
15
126
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
99
991
0.99
0.00
10.1
8.2
u/l
28.0
26.8
0.19
94
946
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
54
0.92
0.00
1.0
1.4
—
—
—
0
0
(4010399)
5
49
1.02
0.00
1.4
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
10.2
—
0
6
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
577.6
—
0
5
(3000093) Morphology [Interpretation] in Blood Narrative
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
7
0.00
0.00
0.0
5.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
1.6
—
106.3
—
0
8
(3004616) Nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.6
—
93.6
—
0
5
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
5.9
—
0
5
(40768806) Pleura Pathology biopsy report
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
3.0
—
27.5
—
0
6
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
8
0.00
0.00
0.0
3.8
—
—
—
0
0
(4211845)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3019225) pH of Specimen
6
66
0.90
0.00
2.0
4.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
1.6
—
4.1
—
0
8
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
10.4
—
0
5
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
10.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
0.9
—
0
7
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_TRAUMAT_CEREBRAL_OEDEMA – Traumatic cerebral oedema
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).